Zinc Oxide Nanoparticles: A Promising Antiviral Therapy of Lumpy Skin Disease Virus in Vitro | ||||
Egyptian Journal of Veterinary Sciences | ||||
Volume 55, Issue 1, January and February 2024, Page 157-173 PDF (2.21 MB) | ||||
Document Type: Original Article | ||||
DOI: 10.21608/ejvs.2023.219490.1530 | ||||
View on SCiNiTO | ||||
Authors | ||||
Gabr Fikry El-Bagoury1; Essam Isamail El-Toukhy 2; Mohammed Gamal El-hamady 3; Samr Kassem 4 | ||||
1virology department, faculty of veterinary medicine, Benha university, Egypt | ||||
2Biotechnology department, Animal Health Research Institute (AHRI), Dokki, Agriculture Research Center (ARC), Giza, Egypt | ||||
3Department of biotechnology, Animal health research institute (AHRI), Agriculture research center (ARC), Giza, Egypt | ||||
4Nanomaterials Research and Synthesis Unit, Animal Health Research Institute (AHRI), Dokki, Agriculture research center (ARC), Giza, Egypt. | ||||
Abstract | ||||
Five nodular samples were collected from clinically suspected cattle for lumpy skin disease (LSD) from five governorates in Egypt during 2020. Real-time PCR confirmed the presence of lumpy skin disease (LSDV) in all samples. One sample was isolated and passaged three times on the chorio-allantoic membrane (CAM) of specific pathogen free embryonated chicken eggs (SPF-ECEs), resulting in the formation of pock lesions. The isolated sample underwent partial gene sequencing of the G-protein coupled chemokine receptor (GPCR) gene for molecular characterization, revealing its close relation to circulating LSDV strains in Africa and the Middle East. Subsequently, zinc oxide nanoparticles (ZnONPs) were synthesised using a green method with zinc sulphate heptahydrate as a precursor and Arabic gum as a stabilizer. Characterization of ZnONPs using Fourier transform spectroscopy (FT-IR), zetasizer, X-ray diffraction (XRD), and transmission electron microscopy (TEM) showed a size range of 23.6 to 38.0 nm and a surface charge of -25.7 mV. The cytotoxicity of ZnONPs was evaluated on human oral epithelial cells (OEC), showing that the survival rate of cells decreased from 100.99 to 90.23% at concentrations of 0.31 and 50 mg/ml respectively. ZnONPs were used to inhibit LSDV replication in Madin Darby bovine kidney (MDBK) tissue culture using plaque reduction assay showing 50% inhibitory concentration (IC50) at 45.36 µg/ml and cytotoxicity (CC50) at 30.9 µg/ml with a selectivity index of 0.68. Furthermore, TEM imaging confirmed the antiviral efficacy of ZnONPs against LSDV. These findings demonstrate the antiviral effect of ZnONPs against LSDV, offering promising applications in veterinary medicine field. | ||||
Keywords | ||||
LSDV; Real time PCR; GPCR; Antiviral; zinc oxide nanoparticles | ||||
Statistics Article View: 297 PDF Download: 206 |
||||